++
Chapter 36. Intervention in Venous and Arterial Grafts
++
++
++
The use of embolic protection in saphenous vein graft (SVG) stent implantation in the randomized SAFER trial was associated with which of the following outcomes?
++
++
++
A. No impact on occurrence of major adverse cardiac events (MACE)
++
++
++
++
++
++
+
++
++
++
++
The rate of SVG failure at 1 year after coronary artery bypass graft (CABG) in routinely performed angiographic studies was shown to be which of the following?
++
++
++
++
++
++
++
++
++
+
++
++
++
++
Use of slightly oversized stents in SVGs has been associated with which of the following outcomes?
++
++
++
A. Reduced target vessel revascularization
++
++
B. Reduced periprocedural infarction
++
++
C. Increased periprocedural MACE
++
++
+
++
++
++
++
Use of drug-eluting stents in SVGs compared to bare metal stents was associated with which of the following in randomized trials?
++
++
++
++
++
B. Reduced myocardial infarction
++
++
C. Reduced stent thrombosis
++
++
+
++
++
++
++
When used in SVGs prior to stent implantation, atheroablative strategies were shown to be associated with which of the following?
++
++
++
A. Increased cost and reduced restenosis
++
++
B. Increased cost and similar restenosis
++
++
C. Similar cost and outcome
++
++
D. Increased complications
+
++